Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : ASK Vendit Off Topic Questions -- Ignore unavailable to you. Want to Upgrade?

To: Vendit™ who wrote (10097)	3/21/2000 11:14:00 AM
From: nohalo	Read Replies (1) \| Respond to of 19374

RE: ASTM news. Saw the news release this am. Essentially, ASTM is trying to get the lead in stem cell research and applications, and moving to sell their technologies to hospital research labs. Fascinating field with many long term positive implications. As you know, ASTM has quintupled in price over the past few months, and has not given ground during the recent biotech selloff. I think ASTM is a buy under 5. It is a longer term play, though. If you push me to the wall, I would hazard a guesstimate target of around 50. As you know, I bought ASTM at 1.11, and added at 4 3/4. I will buy more, on a day when they don't issue any press releases! All the best, DA